Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimal COVID-19 quarantine and testing strategies

View ORCID ProfileChad R. Wells, Jeffrey P. Townsend, View ORCID ProfileAbhishek Pandey, Gary Krieger, Burton Singer, Robert H. McDonald, Seyed M. Moghadas, Alison P. Galvani
doi: https://doi.org/10.1101/2020.10.27.20211631
Chad R. Wells
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chad R. Wells
Jeffrey P. Townsend
2Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut 06510, USA
3Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut 06525, USA
4Program in Computational Biology and Bioinformatics, Yale University, New Haven, Connecticut 06511, USA
5Program in Microbiology, Yale University, New Haven, Connecticut 06511, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Jeffrey.Townsend@Yale.edu
Abhishek Pandey
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abhishek Pandey
Gary Krieger
6NewFields LLC Boulder, CO USA 30301 and Skaggs School of Pharmacy and Pharmaceutical Science, University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Burton Singer
7Emerging Pathogens Institute, University of Florida, P.O. Box 100009, Gainesville, FL 32610, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert H. McDonald
8Group Health, Safety and Environment; BHP; Melbourne, Victoria, Australia, 3000
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seyed M. Moghadas
9Agent-Based Modelling Laboratory, York University, Toronto, Ontario, M3J 1P3 Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison P. Galvani
1Center for Infectious Disease Modeling and Analysis (CIDMA), Yale School of Public Health, New Haven, CT 06520, USA
3Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut 06525, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

As economic woes of the COVID-19 pandemic deepen, strategies are being formulated to avoid the need for prolonged stay-at-home orders, while implementing risk-based quarantine, testing, contact tracing and surveillance protocols. Given limited resources and the significant economic, public health and operational challenges of the current 14-day quarantine recommendation, it is vital to understand if more efficient but equally effective quarantine and testing strategies can be deployed. To this end, we developed a mathematical model to quantify the probability of post-quarantine transmission that varied across a range of possible quarantine durations, timings of molecular testing, and entry uniformly across infection time course or entry as a traced contact. Assuming cases entering quarantine uniformly across infection time course and a one-day delay for testing and, we found that a 13-day quarantine with testing on entry, a seven-day quarantine with testing on exit, and a seven-day quarantine with testing on both entry and exit each provide equivalent or lower probability of post-quarantine transmission compared to a 14-day quarantine with no testing. We found that testing on exit from quarantine is more effective in reducing probability of post-quarantine transmission than testing upon entry. When conducting a single test, testing on exit was most effective for quarantines lasting up to six days. For longer quarantines, the optimal test day was day five or day six. These results differed by no more than one day for cases entering quarantine as traced contacts. Optimal timing of testing during quarantine will reduce the probability of post-quarantine transmission, as false-positive results become less likely, enabling case isolation. Based on 4,040 SARS CoV-2 RT-PCR tests, an exit test 96 hours after the start of quarantine for an offshore oil rig population was demonstrated to identify all known asymptomatic cases that previously tested negative at entry, and—moreover—successfully prevented an expected nine offshore transmission events, each a serious concern for initiating rapid spread and a disabling outbreak in the close quarters of an offshore rig. This successful outcome highlights the importance of context-specific guidelines for the duration of quarantine and timing of testing that can minimize economic impacts, disruptions to operational integrity, and COVID-related public health risks.

  • Coronavirus
  • quarantine
  • viral shedding
  • disease control
  • testing
  • contact tracing

Competing Interest Statement

JTP, GK,BS,RHM,SMM, APG received funding from the company who collected and provided data

Funding Statement

J.P.T. gratefully acknowledges funding from the National Science Foundation grant CCF 1918656, the Elihu endowment, Notsew Orm Sands Foundation, and BHP. G.K., B.S., and R.H.M acknowledge funding from BHP. S.M.M. acknowledges support from the Canadian Institutes of Health Research (grant OV4-170643; Canadian 2019 Novel Coronavirus Rapid Research), the Natural Sciences and Engineering Research Council of Canada, and BHP. A.P.G. gratefully acknowledges funding from NIH UO1-GM087719, the Burnett and Stender families' endowment, the Notsew Orm Sands Foundation, and BHP.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB Approval from the Office of Research Ethics (ORE) at York University, Toronto ON, Canada Certificate #: 2020-323 (Approval Document can be provided if requested)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The number of positive tests and tests conducted at the two regions quarantining the crew members heading offshore are presented in Fig. 2, with other data used in the analysis referenced in Table S1 and in the Methods.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimal COVID-19 quarantine and testing strategies
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimal COVID-19 quarantine and testing strategies
Chad R. Wells, Jeffrey P. Townsend, Abhishek Pandey, Gary Krieger, Burton Singer, Robert H. McDonald, Seyed M. Moghadas, Alison P. Galvani
medRxiv 2020.10.27.20211631; doi: https://doi.org/10.1101/2020.10.27.20211631
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Optimal COVID-19 quarantine and testing strategies
Chad R. Wells, Jeffrey P. Townsend, Abhishek Pandey, Gary Krieger, Burton Singer, Robert H. McDonald, Seyed M. Moghadas, Alison P. Galvani
medRxiv 2020.10.27.20211631; doi: https://doi.org/10.1101/2020.10.27.20211631

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)